Effect of a new functional CYP3A4 polymorphism on calcineurin inhibitors’’ dose requirements and trough blood levels in stable renal transplant patients

Author： Elens Laure   van Schaik Ron H   Panin Nadtha   de Meyer Martine   Wallemacq Pierre   Lison Dominique   Mourad Michel   Haufroid Vincent  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.10, 2011-10, pp. : 1383-1396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients

By Santoro Ana   Felipe Claudia R   Tedesco-Silva Helio   Medina-Pestana Jose O   Struchiner Claudio J   Ojopi Elida B   Suarez-Kurtz Guilherme  

Pharmacogenomics, Vol. 12, Iss. 9, 2011-09 ,pp. : 1293-1303

Future Medicine

Access to resources Recommend Favorite

Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimus pharmacokinetics in renal transplant patients

By Miura Masatomo   Satoh Shigeru   Kagaya Hideaki   Saito Mitsuru   Numakura Kazuyuki   Tsuchiya Norihiko   Habuchi Tomonori  

Pharmacogenomics, Vol. 12, Iss. 7, 2011-07 ,pp. : 977-984

Future Medicine

Access to resources Recommend Favorite

Calcineurin Inhibitors in Pediatric Renal Transplant Recipients

By Filler Guido  

Pediatric Drugs, Vol. 9, Iss. 3, 2007-01 ,pp. : 165-174

Adis International

Access to resources Recommend Favorite

A non-invasive CYP3A4 biomarker and body mass index predict cyclosporine dosage requirements in Chinese renal transplant recipients

By Cai Ningfang   Li Bifeng   Huang Xiaohong   Xu Kezhen   Feng Huiping   Cheng Zeneng   Zhu Lijun   Zheng Liyun   Luo Xi  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 12, 2015-12 ,pp. : 815-818

Govi-Verlag

Access to resources Recommend Favorite

Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on the Pharmacokinetics of the Prolonged-Release, Once-Daily Formulation of Tacrolimus in Stable Renal Transplant Recipients

By Glowacki François   Lionet Arnaud  

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 451-459

Adis International

Access to resources Recommend Favorite